Literature DB >> 29799677

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.

David Bursill1, William J Taylor2, Robert Terkeltaub3, Masanari Kuwabara4, Tony R Merriman5, Rebecca Grainger2, Carlos Pineda6, Worawit Louthrenoo7, N Lawrence Edwards8, Mariano Andrés9, Ana Beatriz Vargas-Santos10, Edward Roddy11, Tristan Pascart12, Ching-Tsai Lin13, Fernando Perez-Ruiz14, Sara K Tedeschi15, Seoyoung C Kim15, Leslie R Harrold16, Geraldine McCarthy17, Nitin Kumar18, Peter T Chapman19, Anne-Kathrin Tausche20, Janitzia Vazquez-Mellado21, Marwin Gutierrez22, Geraldo da Rocha Castelar-Pinheiro10, Pascal Richette23, Eliseo Pascual9, Mark C Fisher24, Ruben Burgos-Vargas21, Philip C Robinson25, Jasvinder A Singh26, Tim L Jansen27, Kenneth G Saag28, Ole Slot29, Tillmann Uhlig30, Daniel H Solomon15, Robert T Keenan31, Carlo Alberto Scire32, Edyta Biernat-Kaluza33, Mats Dehlin34, George Nuki35, Naomi Schlesinger36, Matthijs Janssen27, Lisa K Stamp37, Francisca Sivera38, Anthony M Reginato39, Lennart Jacobsson34, Frédéric Lioté23, Hang-Korng Ea23, Ann Rosenthal40, Thomas Bardin23, Hyon K Choi24, Michael S Hershfield41, Christine Czegley42, Sung Jae Choi43, Nicola Dalbeth44.   

Abstract

OBJECTIVE: The language currently used to describe gout lacks standardization. The aim of this project was to develop a consensus statement on the labels and definitions used to describe the basic disease elements of gout.
METHODS: Experts in gout (n = 130) were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach consensus on the labeling and definitions for the basic disease elements of gout. Disease elements and labels in current use were derived from a content analysis of the contemporary medical literature, and the results of this analysis were used for item selection in the Delphi exercise and face-to-face consensus meeting.
RESULTS: There were 51 respondents to the Delphi exercise and 30 attendees at the face-to-face meeting. Consensus agreement (≥80%) was achieved for the labels of 8 disease elements through the Delphi exercise; the remaining 3 labels reached consensus agreement through the face-to-face consensus meeting. The agreed labels were monosodium urate crystals, urate, hyperuric(a)emia, tophus, subcutaneous tophus, gout flare, intercritical gout, chronic gouty arthritis, imaging evidence of monosodium urate crystal deposition, gouty bone erosion, and podagra. Participants at the face-to-face meeting achieved consensus agreement for the definitions of all 11 elements and a recommendation that the label "chronic gout" should not be used.
CONCLUSION: Consensus agreement was achieved for the labels and definitions of 11 elements representing the fundamental components of gout etiology, pathophysiology, and clinical presentation. The Gout, Hyperuricemia, and Crystal-Associated Disease Network recommends the use of these labels when describing the basic disease elements of gout.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29799677      PMCID: PMC6252290          DOI: 10.1002/acr.23607

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  7 in total

Review 1.  Consensus methods for medical and health services research.

Authors:  J Jones; D Hunter
Journal:  BMJ       Date:  1995-08-05

2.  Towards a coherent terminology of gout.

Authors:  P A Simkin
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

3.  Patient and provider barriers to effective management of gout in general practice: a qualitative study.

Authors:  Karen Spencer; Alison Carr; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2012-03-22       Impact factor: 19.103

Review 4.  Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline.

Authors:  Paul G Shekelle; Sydne J Newberry; John D FitzGerald; Aneesa Motala; Claire E O'Hanlon; Abdul Tariq; Adeyemi Okunogbe; Dan Han; Roberta Shanman
Journal:  Ann Intern Med       Date:  2016-11-01       Impact factor: 25.391

Review 5.  Urate Handling in the Human Body.

Authors:  David Hyndman; Sha Liu; Jeffrey N Miner
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

6.  Computational Lexical Analysis of the Language Commonly Used to Describe Gout.

Authors:  N Lawrence Edwards; Robert Malouf; Fernando Perez-Ruiz; Pascal Richette; Siobhan Southam; Matthew DiChiara
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-06       Impact factor: 4.794

Review 7.  Allopurinol for chronic gout.

Authors:  Rakhi Seth; Alison S R Kydd; Rachelle Buchbinder; Claire Bombardier; Christopher J Edwards
Journal:  Cochrane Database Syst Rev       Date:  2014-10-14
  7 in total
  16 in total

Review 1.  Issues in CPPD Nomenclature and Classification.

Authors:  Sara K Tedeschi
Journal:  Curr Rheumatol Rep       Date:  2019-07-25       Impact factor: 4.592

Review 2.  Update on gout management: what is old and what is new.

Authors:  Yuliya Afinogenova; Abhijeet Danve; Tuhina Neogi
Journal:  Curr Opin Rheumatol       Date:  2022-03-01       Impact factor: 5.006

3.  Tea (Camellia sinensis) Ameliorates Hyperuricemia via Uric Acid Metabolic Pathways and Gut Microbiota.

Authors:  Dan Wu; Ruohong Chen; Qiuhua Li; Xingfei Lai; Lingli Sun; Zhenbiao Zhang; Shuai Wen; Shili Sun; Fanrong Cao
Journal:  Nutrients       Date:  2022-06-27       Impact factor: 6.706

4.  Tea and its components reduce the production of uric acid by inhibiting xanthine oxidase.

Authors:  Dan Wu; Ruohong Chen; Wenji Zhang; Xingfei Lai; Lingli Sun; Qiuhua Li; Zhenbiao Zhang; Junxi Cao; Shuai Wen; Zhaoxiang Lai; Zhigang Li; Fanrong Cao; Shili Sun
Journal:  Food Nutr Res       Date:  2022-06-15       Impact factor: 3.221

Review 5.  Dietary supplements for chronic gout.

Authors:  Mariano Andrés; Francisca Sivera; Rachelle Buchbinder; Jordi Pardo Pardo; Loreto Carmona
Journal:  Cochrane Database Syst Rev       Date:  2021-11-12

6.  Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Authors:  David Bursill; William J Taylor; Robert Terkeltaub; Abhishek Abhishek; Alexander K So; Ana Beatriz Vargas-Santos; Angelo Lino Gaffo; Ann Rosenthal; Anne-Kathrin Tausche; Anthony Reginato; Bernhard Manger; Carlo Sciré; Carlos Pineda; Caroline van Durme; Ching-Tsai Lin; Congcong Yin; Daniel Arthur Albert; Edyta Biernat-Kaluza; Edward Roddy; Eliseo Pascual; Fabio Becce; Fernando Perez-Ruiz; Francisca Sivera; Frédéric Lioté; Georg Schett; George Nuki; Georgios Filippou; Geraldine McCarthy; Geraldo da Rocha Castelar Pinheiro; Hang-Korng Ea; Helena De Almeida Tupinambá; Hisashi Yamanaka; Hyon K Choi; James Mackay; James R ODell; Janitzia Vázquez Mellado; Jasvinder A Singh; John D Fitzgerald; Lennart T H Jacobsson; Leo Joosten; Leslie R Harrold; Lisa Stamp; Mariano Andrés; Marwin Gutierrez; Masanari Kuwabara; Mats Dehlin; Matthijs Janssen; Michael Doherty; Michael S Hershfield; Michael Pillinger; N Lawrence Edwards; Naomi Schlesinger; Nitin Kumar; Ole Slot; Sebastien Ottaviani; Pascal Richette; Paul A MacMullan; Peter T Chapman; Peter E Lipsky; Philip Robinson; Puja P Khanna; Rada N Gancheva; Rebecca Grainger; Richard J Johnson; Ritch Te Kampe; Robert T Keenan; Sara K Tedeschi; Seoyoung Kim; Sung Jae Choi; Theodore R Fields; Thomas Bardin; Till Uhlig; Tim Jansen; Tony Merriman; Tristan Pascart; Tuhina Neogi; Viola Klück; Worawit Louthrenoo; Nicola Dalbeth
Journal:  Ann Rheum Dis       Date:  2019-09-09       Impact factor: 19.103

7.  A Randomized Controlled Trial of Chuanhutongfeng Mixture for the Treatment of Chronic Gouty Arthritis by Regulating miRNAs.

Authors:  Yao Wang; Liping Dong; Peng Liu; Ying Chen; Shaodan Jia; Yangang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-03       Impact factor: 2.629

8.  LncRNAs Landscape in the patients of primary gout by microarray analysis.

Authors:  Yu-Feng Qing; Jian-Xiong Zheng; Yi-Ping Tang; Fei Dai; Zeng-Rong Dong; Quan-Bo Zhang
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

9.  Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death.

Authors:  Lisandro D Colantonio; Richard J Reynolds; Tony R Merriman; Angelo Gaffo; Jasvinder A Singh; Timothy B Plante; Ninad S Chaudhary; Nicole D Armstrong; Elsayed Z Soliman; Jeffrey R Curtis; S Louis Bridges; Leslie Lang; George Howard; Monika M Safford; Kenneth G Saag; Paul Muntner; Marguerite Ryan Irvin
Journal:  J Rheumatol       Date:  2021-06-15       Impact factor: 4.666

10.  Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study : MSU burden and risk of gout flare.

Authors:  Tristan Pascart; Agathe Grandjean; Benoist Capon; Julie Legrand; Nasser Namane; Vincent Ducoulombier; Marguerite Motte; Marie Vandecandelaere; Hélène Luraschi; Catherine Godart; Eric Houvenagel; Laurène Norberciak; Jean-François Budzik
Journal:  Arthritis Res Ther       Date:  2018-09-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.